Search
Now showing items 1-10 of 10
Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase
Jawhar, Mohamad et al. (2017)
Wissenschaftlicher Artikel
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis
Jawhar, Mohamad et al. (2019)
Wissenschaftlicher Artikel
Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML
Fabarius, Alice et al. (2015)
Wissenschaftlicher Artikel
Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV
Hehlmann, Ruediger et al. (2014)
Wissenschaftlicher Artikel
Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV
Kalmanti, Lida et al. (2014)
Wissenschaftlicher Artikel
Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV
Fabarius, Alice et al. (2011)
Wissenschaftlicher Artikel
Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV
Saussele, Susanne et al. (2018)
Wissenschaftlicher Artikel
Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib
Hanfstein, Benjamin et al. (2014)
Wissenschaftlicher Artikel
Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib
Hanfstein, Benjamin et al. (2014)
Wissenschaftlicher Artikel
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV
Michel, Christian et al. (2019)
Wissenschaftlicher Artikel